EUVIMEDEUVIMED entdecken
Crossref

Alternative Structural Lipids Impact mRNA-Lipid Nanoparticle Morphology, Stability, and Activity

Chelsea R Thorn, James Collin Hickey, Ying-Chih Chi, Mingzhang Maple Wang, Karina Ng Huang, Sue-Jean Hong, Qin Zou, Hong-My Nguyen, Roger H Pak, Patrick Lim Soo iD

Molecular Pharmaceutics · 05.01.2026 · 23 (1) · 209-223

DOI: 10.1021/acs.molpharmaceut.5c00824 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 26.11.2025. Verfasst von Chelsea R Thorn und 9 weiteren Autor:innen. Beteiligte Einrichtung: BioTherapeutics Pharmaceutical Sciences, Pharmaceutical Research and Development, Pfizer Inc., Andover, Massachusetts 01810, United States. Hauptthemen laut MEDLINE: Nanoparticles, RNA, Messenger, Lipids. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: U.S. Department of Energy (DOE).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lipid nanoparticles (LNPs) are critical drug delivery vehicles that enable functional mRNA delivery into cells to produce desired proteins, enabling vaccine and therapeutic applications. The structure and formulation of mRNA-containing LNPs (mRNA-LNPs) critically impact the delivery and protein production. Here, we generated LNPs with various structural lipids to improve the nanoparticle drug product stability and delivery profiles. We incorporated glyceryl monooleate and phytantriol as alternatives to traditional phospholipids (e.g., distearoylphosphatidylcholine). The physicochemical attributes of mRNA-LNPs were assessed by the hydrodynamic particle size, mRNA encapsulation, and mRNA integrity. mRNA-LNP morphology was assessed by synchrotron small-angle X-ray scattering, pulsed gradient stimulated echo proton nuclear magnetic resonance, and cryogenic-transmission electron microscopy. In vitro activity, including transfection and cytokine stimulation were evaluated in HeLa cells and whole human blood, respectively, for select mRNA-LNPs with varied morphologies. Alternative structural lipids in mRNA-LNPs produced different mesophases depending on the lipid type and molar ratio. Specific lipid combinations yielded distinct quality attributes and stability profiles, with unique in vitro activities. Hexagonal and cubic phase structures enhanced mRNA-LNP stability at refrigerated and room temperatures for over six months and three months, respectively. These novel mRNA-LNPs provided promising benefits by reducing immunostimulatory cytokines, warranting further exploration. Our efforts demonstrate the nuances of LNP composition and its effects on structure, stability, and activity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesRNA, MessengerLipidsHumansHeLa CellsParticle SizeGlyceridesTransfectionDrug Delivery SystemsFatty AlcoholsLiposomes

Stichwörter der Autor:innen

lipid nanoparticlesmRNAmesophasenanoparticlesvaccine

Substanzen

RNA, MessengerLipidsGlyceridesmonooleinLipid Nanoparticles3,7,11,15-tetramethyl-1,2,3-hexadecanetriolFatty AlcoholsLiposomes

Autor:innen und Institutionen

  • BioTherapeutics Pharmaceutical Sciences, Pharmaceutical Research and Development, Pfizer Inc., Andover, Massachusetts 01810, United States.
  • BioMedicine Design, Pfizer Inc., Cambridge, Massachusetts 02139, United States.
  • BioTherapeutics Pharmaceutical Sciences, Analytical Research and Development, Pfizer Inc., St. Louis, Missouri 63017, United States.
  • Vaccines Research and Development, Pfizer Inc., Pearl River, New York 10965, United States.
  • Drug Safety Research & Development, Pfizer Inc, Groton, Connecticut 06340, United States.

ORCID-Profile: Patrick Lim Soo

Förderung

  • U.S. Department of Energy (DOE)

Zitieren

APA

Thorn, C. R., Hickey, J. C., Chi, Y. C., Wang, M. M., Ng Huang, K., Hong, S. J., Zou, Q., Nguyen, H. M., Pak, R. H., & Lim Soo, P. (2026). Alternative Structural Lipids Impact mRNA-Lipid Nanoparticle Morphology, Stability, and Activity. Molecular Pharmaceutics, 23(1), 209-223. https://doi.org/10.1021/acs.molpharmaceut.5c00824

Vancouver

Thorn CR, Hickey JC, Chi YC, Wang MM, Ng Huang K, Hong SJ, et al. Alternative Structural Lipids Impact mRNA-Lipid Nanoparticle Morphology, Stability, and Activity. Molecular Pharmaceutics. 2026;23(1):209-223. doi:10.1021/acs.molpharmaceut.5c00824

BibTeX
@article{Thorn2026,
  author = {Thorn, Chelsea R and Hickey, James Collin and Chi, Ying-Chih and Wang, Mingzhang Maple and Ng Huang, Karina and Hong, Sue-Jean and Zou, Qin and Nguyen, Hong-My and Pak, Roger H and Lim Soo, Patrick},
  title = {Alternative Structural Lipids Impact mRNA-Lipid Nanoparticle Morphology, Stability, and Activity},
  journal = {Molecular Pharmaceutics},
  year = {2026},
  volume = {23},
  number = {1},
  pages = {209--223},
  doi = {10.1021/acs.molpharmaceut.5c00824}
}
Kostenlos starten →